Board of Directors
NB32 in Europe
Our Approach to Obesity Treatment
Events, Presentations, and Webcasts
Q & A About Clinical Trials
Meet Some of the Team
Health and Financial Benefits
OREXIGEN THERAPEUTICS, INC.
We are a biopharmaceutical company focused on the treatment of obesity...
Get to know our leadership team and learn about our collaborators...
WHO WE ARE
Meet the team and learn about exciting career opportunities at Orexigen...
Frontpage Slideshow | Copyright © 2006-2011 JoomlaWorks Ltd.
Who We Are
"I joined Orexigen in 2007 to be part of a company with a strong vision and focus dedicated to making a difference..."
NEWS & ANNOUNCEMENTS
Takeda and Orexigen Announce Availability of CONTRAVE (naltrexone HCI and bupropion HCI) Extended-Release Tablets for Chronic Weight Management in Obese Adults
Click here for full Prescribing Information including BOXED WARNING »
Learn more about Contrave® »
Copyright© 2014 Orexigen Therapeutics, Inc.. All rights reserved.
Terms & Conditions